G. Alignement-génomique-des-read-dans-next, Exemple de la mutation c, p.100

F. Grizzi and M. Chiriva-internati, Cancer: looking for simplicity and finding complexity, Cancer Cell International, vol.6, issue.1, p.4, 2006.
DOI : 10.1186/1475-2867-6-4

B. Vogelstein and K. W. Kinzler, Cancer genes and the pathways they control, Nature Medicine, vol.23, issue.8, pp.789-799, 2004.
DOI : 10.1038/sj.onc.1207130

C. Houdayer and D. Stoppa-lyonnet, Anomalies de la transcription et diagnostic en g??n??tique constitutionnelle, m??decine/sciences, vol.21, issue.2, pp.170-174, 2005.
DOI : 10.1051/medsci/2005212170

URL : http://www.medecinesciences.org/articles/medsci/pdf/2005/02/medsci2005212p170.pdf

D. Stoppa-lyonnet, M. H. Stern, N. Soufir, and G. Lenoir, Pr??dispositions g??n??tiques aux cancers??: actualit??s et perspectives en 2010, Pathologie Biologie, vol.58, issue.5, pp.324-330, 2010.
DOI : 10.1016/j.patbio.2010.02.004

URL : http://www.erudit.org/fr/revues/ms/2005-v21-n11-ms1020/011962ar.pdf

C. Garnis, T. P. Buys, and W. L. Lam, Genetic alteration and gene expression modulation during cancer progression, Molecular Cancer, vol.3, issue.1, p.9, 2004.
DOI : 10.1186/1476-4598-3-9

C. Sawan, T. Vaissière, R. Murr, and Z. Herceg, Epigenetic drivers and genetic passengers on the road to cancer, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.642, issue.1-2, pp.1-13, 2008.
DOI : 10.1016/j.mrfmmm.2008.03.002

J. Ferlay, D. M. Parkin, and E. Steliarova-foucher, Estimates of cancer incidence and mortality in Europe in 2008, European Journal of Cancer, vol.46, issue.4, pp.765-781, 1990.
DOI : 10.1016/j.ejca.2009.12.014

. Binder-foucard, Estimation nationale de l'incidence et de la mortalité par cancer en France entre, 1980.

D. Stoppa-lyonnet and G. Lenoir, Pr??dispositions g??n??tiques aux cancers : Actualit??s et perspectives en 2005, m??decine/sciences, vol.21, issue.11, pp.962-968, 2005.
DOI : 10.1051/medsci/20052111962

URL : http://www.medecinesciences.org/articles/medsci/pdf/2005/09/medsci20052111p962.pdf

N. Mavaddat, Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE, JNCI: Journal of the National Cancer Institute, vol.4, issue.3, pp.812-822, 2013.
DOI : 10.1016/j.molonc.2010.04.011

D. K. Bartsch, T. M. Gress, and P. Langer, Familial pancreatic cancer???current knowledge, Nature Reviews Gastroenterology & Hepatology, vol.7, issue.8, pp.445-453, 2012.
DOI : 10.1159/000108969

Y. Miki, A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1, Science, vol.266, issue.5182, pp.66-71, 1994.
DOI : 10.1126/science.7545954

C. I. Szabo, Human, canine and murine BRCA1 genes: sequence comparison among species, Human Molecular Genetics, vol.5, issue.9, pp.1289-1298, 1996.
DOI : 10.1093/hmg/5.9.1289

URL : https://academic.oup.com/hmg/article-pdf/5/9/1289/1661461/5-9-1289.pdf

R. Wooster, Identification of the breast cancer susceptibility gene BRCA2, Nature, vol.72, issue.6559, pp.789-792, 1995.
DOI : 10.1038/bjc.1995.493

S. V. Tavtigian, The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds, Nature Genetics, vol.8, issue.3, pp.333-337, 1996.
DOI : 10.1001/jama.273.7.535

F. Esashi, CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair, Nature, vol.12, issue.7033, pp.598-604, 2005.
DOI : 10.1101/gad.12.24.3831

L. A. Chodosh, Expression of BRCA1 and BRCA2 in normal and neoplastic cells, Journal of Mammary Gland Biology and Neoplasia, vol.3, issue.4, pp.389-402, 1998.
DOI : 10.1023/A:1018784031651

R. Roy, J. Chun, and S. N. Powell, BRCA1 and BRCA2: different roles in a common pathway of genome protection, Nature Reviews Cancer, vol.336, issue.1, pp.68-78, 2012.
DOI : 10.1056/NEJM199705153362003

S. F. Anderson, B. P. Schlegel, T. Nakajima, E. S. Wolpin, and J. Parvin, BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A, Nature Genetics, vol.92, issue.3, pp.254-256, 1998.
DOI : 10.1073/pnas.92.19.8871

A. A. Horwitz, E. B. Affar, G. F. Heine, Y. Shi, and J. D. Parvin, A mechanism for transcriptional repression dependent on the BRCA1 E3 ubiquitin ligase, Proc. Natl. Acad
DOI : 10.1073/pnas.082117599

N. Suwaki, K. Klare, and M. Tarsounas, RAD51 paralogs: Roles in DNA damage signalling, recombinational repair and tumorigenesis, Seminars in Cell & Developmental Biology, vol.22, issue.8, pp.898-905, 2011.
DOI : 10.1016/j.semcdb.2011.07.019

S. Caputo, Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases, Nucleic Acids Research, vol.6, issue.D1, pp.992-1002, 2012.
DOI : 10.1016/j.bbapap.2007.03.018

URL : https://hal.archives-ouvertes.fr/hal-01681814

R. Ferla, Founder mutations in BRCA1 and BRCA2 genes, Annals of Oncology, vol.18, issue.Supplement 6, pp.93-98, 2007.
DOI : 10.1093/annonc/mdm234

T. Ripperger, D. Gadzicki, A. Meindl, and B. Schlegelberger, Breast cancer susceptibility: current knowledge and implications for genetic counselling, European Journal of Human Genetics, vol.22, issue.6, pp.722-731, 2009.
DOI : 10.1371/journal.pgen.1000054

URL : http://europepmc.org/articles/pmc2947107?pdf=render

S. Casadei, Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer, Cancer Research, vol.71, issue.6, pp.2222-2229, 2011.
DOI : 10.1158/0008-5472.CAN-10-3958

N. Rahman, PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene, Nature Genetics, vol.31, issue.2, pp.165-167, 2007.
DOI : 10.1016/j.tibs.2006.05.004

A. Meindl, Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene, Nature Genetics, vol.668, issue.5, pp.410-414, 2010.
DOI : 10.1016/S0301-472X(02)00782-8

K. Michailidou, Large-scale genotyping identifies 41 new loci associated with breast cancer risk, Nature Genetics, vol.52, issue.4, pp.353-361, 2013.
DOI : 10.1371/journal.pgen.1002639

L. Melchor and J. Benítez, The complex genetic landscape of familial breast cancer, Human Genetics, vol.134, issue.3, pp.845-863, 2013.
DOI : 10.1007/s10549-012-2141-2

. Burge, 20 Splicing of Precursors to mRNAs by the Spliceosomes. at <http://cshmonographs.org/index

L. Cartegni, S. L. Chew, and A. Krainer, Listening to silence and understanding nonsense: exonic mutations that affect splicing, Nature Reviews Genetics, vol.63, issue.Suppl. 1, pp.285-298, 2002.
DOI : 10.1086/302119

D. L. Black, Mechanisms of Alternative Pre-Messenger RNA Splicing, Annual Review of Biochemistry, vol.72, issue.1, pp.291-336, 2003.
DOI : 10.1146/annurev.biochem.72.121801.161720

K. Garg and P. Green, Differing patterns of selection in alternative and constitutive splice sites, Genome Research, vol.17, issue.7, pp.1015-1022, 2007.
DOI : 10.1101/gr.6347907

R. Sorek and G. Ast, Intronic Sequences Flanking Alternatively Spliced Exons Are Conserved Between Human and Mouse, Genome Research, vol.13, issue.7, pp.1631-1637, 2003.
DOI : 10.1101/gr.1208803

URL : http://genome.cshlp.org/content/13/7/1631.full.pdf

N. Kim and C. Lee, Bioinformatics Detection of Alternative Splicing, Methods Mol. Biol. Clifton NJ, vol.452, pp.179-197, 2008.
DOI : 10.1007/978-1-60327-159-2_9

C. L. Zheng, X. Fu, and M. Gribskov, Characteristics and regulatory elements defining constitutive splicing and different modes of alternative splicing in human and mouse, RNA, vol.11, issue.12, pp.1777-1787, 2005.
DOI : 10.1261/rna.2660805

D. Holste and U. Ohler, Strategies for Identifying RNA Splicing Regulatory Motifs and Predicting Alternative Splicing Events, PLoS Computational Biology, vol.123, issue.1, p.21, 2008.
DOI : 10.1371/journal.pcbi.0040021.st005

URL : http://doi.org/10.1371/journal.pcbi.0040021

C. Houdayer, In Silico Prediction of Splice-Affecting Nucleotide Variants, Methods Mol. Biol. Clifton NJ, vol.760, pp.269-281, 2011.
DOI : 10.1007/978-1-61779-176-5_17

E. Nagy and L. E. Maquat, A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance, Trends in Biochemical Sciences, vol.23, issue.6, pp.198-199, 1998.
DOI : 10.1016/S0968-0004(98)01208-0

A. L. Silva and L. Romão, The mammalian nonsense-mediated mRNA decay pathway: To decay or not to decay! Which players make the decision?, FEBS Letters, vol.17, issue.3, pp.499-505, 2009.
DOI : 10.1093/emboj/17.18.5427

C. Andreutti-zaugg, R. J. Scott, and R. Iggo, Inhibition of nonsense-mediated messenger RNA decay in clinical samples facilitates detection of human MSH2 mutations with an in vivo fusion protein assay and conventional techniques, Cancer Res, vol.57, pp.3288-3293, 1997.

T. I. Orban and E. Olah, Emerging roles of BRCA1 alternative splicing, Molecular Pathology, vol.56, issue.4, pp.191-197, 2003.
DOI : 10.1136/mp.56.4.191

I. H. Consortium, Finishing the euchromatic sequence of the human genome, Nature, vol.8, issue.7011, pp.931-945, 2004.
DOI : 10.1073/pnas.0307971100

M. L. Metzker, Sequencing technologies ??? the next generation, Nature Reviews Genetics, vol.37, issue.1, pp.31-46, 2010.
DOI : 10.1016/j.tig.2007.12.006

L. Orlando, True single-molecule DNA sequencing of a pleistocene horse bone, Genome Research, vol.21, issue.10
DOI : 10.1101/gr.122747.111

A. N. Egan, J. Schlueter, and D. M. Spooner, Applications of next-generation sequencing in plant biology, American Journal of Botany, vol.99, issue.2, pp.175-185, 2012.
DOI : 10.3732/ajb.1200020

N. A. Fonseca, J. Rung, A. Brazma, and J. C. Marioni, Tools for mapping high-throughput sequencing data, Bioinformatics, vol.28, issue.24, p.605, 2012.
DOI : 10.1093/bioinformatics/btr712

R. Nielsen, J. S. Paul, A. Albrechtsen, and Y. S. Song, Genotype and SNP calling from next-generation sequencing data, Nature Reviews Genetics, vol.25, issue.6, pp.443-451, 2011.
DOI : 10.1093/bioinformatics/btp352

URL : http://europepmc.org/articles/pmc3593722?pdf=render

J. A. Martin and Z. Wang, Next-generation transcriptome assembly, Nature Reviews Genetics, vol.323, issue.10, pp.671-682, 2011.
DOI : 10.1126/science.1162986

URL : https://digital.library.unt.edu/ark:/67531/metadc830328/m2/1/high_res_d/1076789.pdf

J. Tarabeux, Streamlined ion torrent PGM-based diagnostics: BRCA1 and BRCA2 genes as a model, European Journal of Human Genetics, vol.6, issue.4, 2013.
DOI : 10.1371/journal.pone.0025531

. Agencourt, Pour une bonne purification, respecter un ratio échantillon

S. Qu, il ne reste pas de billes streptavidine

L. Troubleshooting, initialisation peut parfois échouer car le PGM n'a pas réussi à ajuster le pH de la solution W2 à 7,65

. Ajouter, juste après la fin du programme

>. Les-séquences-de-référence, «. B. Gbk, ». , and «. Brca2, gbk » (dossier REFS sur le bureau) (3) > le fichier de configuration « SNV.ini » (4) > le répertoire de destination (SNV) (5) > le nombre de patients Questions sur la 2ème analyse: -faut-il repartir du départ, càd des données brutes extraites de KDI, ou seulement vérifier la cohérence des noms de fichiers des données brutes et converties? -puisque l'import des données et l'analyse NextGene se font automatiquement grâce au fichier ".ngjob, 2013.